Member Info for Toukankahmoon

Opti

I believe the quote said “in tandem”

Opti

Then why did CC intend originally to RNS it on 17/1 ?

It’s not as if the SP couldn’t do with some good news.

CJ62

It is very important because we are in a race against the time we have to raise funds if P1b hasn’t produced some convincing results by then I dread to see what the offer price will be.

Tim

Do you even know what a twat is?

At least it’s usefulness for

CJ62

Now my turn.

Given that on 17/01/25 CC intended to RNS the start of P1b dosing, then why hasn’t she done so yet? Could it possibly be because it hasn’t started yet?

CJ62

Yes it is unlikely that they wait until they have all the patents lined up before they start. happy?

Thorn

Isn’t quite that easy. I lived and worked in Baltimore so contacted one of my colleagues who stayed out there. Unless you pay you have to find a free clinic even to find out that you have cancer. So I’m not saying it’s impossible, but I do think it’s more of an obstacle than it is in UK

Thorn

Genuine question.

How would “your man on the street “ get access to the trial?

Anyway I’m just try to think of reasons for the delay.

CJ62

Many hopeful peeps on here continue to pick out the good bits of CC communications and ramp them up. Same people then ignore potentially bad news in the communications or try to alter the meaning It would be laughable if a lot of my hard earned cash wasn’t locked up in the shares.

Optimystic

You’ve jumped thread.

You could well be right or just as well be wrong. Point is we don’t know. But with SP so low and everyone (except IceCool) demanding a good RNS, then announcing start of dosing would be ideal.

Cj63 immediately proves my point.

CJ62 I think your comment was really about IceCool. Wyndrum’s posts may be long but at least they are fact based.

I bet your another that thinks dosing has started and everything is on track.

Why The Essay Too

Just sto posting 🤣

BV

Bit of a give away when you require every post to be good news for Avacta.

It is interesting in that gene editing is a potential treatment for some cancers.

Wyndrum

Stop posting. The pack mentality has taken over. It’s the worst thing about this BB.

CC said;

“Avacta had hoped to announce the dosing of P1b yesterday ( mid Jan ) in tandem with the RNS but it was slightly delayed ( thus imminent really does mean imminent).”

Therefore CC intends to RNS that P1b has started dosing. She hasn’t so therefore P1b hasn’t started dosing.

ALREADY DELETED SIX TIMES - WHY?

This is a question that all Avacta shareholders should want an answer to? It is so fundamentally important that we shouldn’t be left to guess.

I am wondering whether their is an issue over some patients voiding there health insurance if they take part in a P1 clinical trial. After all many will have taken out their policies before ACA was enacted.

Also current SGC treatments have a high success rate, it is mainly collateral damage that kills the patients. Therefore forfeiting conventional treatment to take part in the trial of a novel treatment is a big decision to make.

SammyW

My presumption given Avacta’s track record is that screening is taking longer than anticipated and that dosing hasn’t started. The SP is dire. Do you think CC wouldn’t want to RNS good progress? Does this make sense?

SammyW

Because CC said in January that she intends to RNS the start of P1b dosing

The most interesting part was CC said;

“Avacta had hoped to announce the dosing of P1b yesterday ( mid Jan ) in tandem with the RNS but it was slightly delayed ( thus imminent really does mean imminent).”

So CC intended to RNS the start of P1b dosing and she hasn’t yet. Ergo P1b dosing hasn’t started yet.

Icecool

I know it irritates you when I keep saying it because you love an argument but:

1 I have never disputed your figures. They are impossible to dispute because we don’t have the information. For instance how much will Avacta plough back into R&D. And that’s just one item.

2. For a long time now I have said that we wait on results from P1b or even P2 before SP moves. Just reiterating CC really.

You’ve said at least twice that you like to wind people up. So not sure why you get ticks, presumably those people who appreciate your posts are wind up merchants as well.

Please have a nice rest and come back in April.

I thought this BB would be quiet until April but what with IceCool determined to stir it up with his bonkers calculations - we will find out what Avacta is really worth eventually.

And Wyndrum fretting over the science still. It’s absolutely mind numbing.

My take from CC’s communications (which I’ve posted many times) is that everything (well not DX sale obviously) is waiting on P1b results or maybe even P2. The likely potential partners need this hard data to be confident in making an offer acceptable to CC.

So, no, there isn’t anything to RNS and there won’t be for a while yet. It’s s*d all to do with poor PR. There isn’t anything to relate.

Just f*cking wait.